Back to mobile site

Guggenheim Reiterates Buy Rating on AstraZeneca (AZN:LN) (AZN)

January 14, 2026 1:11 AM EST Send to a Friend
Guggenheim analyst Seamus Fernandez reiterated a Buy rating and GBP155.00 price target on AstraZeneca (AZN:LN) (NASDAQ: AZN).The analyst comments: "At ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login